CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Adcock Ingram Holdings Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Adcock Ingram Holdings Limited
1 New Road, (c/o New Road & 7th Street),
Phone: +27 116350000p:+27 116350000 MIDRAND, 1682  South Africa Ticker: AIPAIP
Business Summary
Adcock Ingram Holdings Limited is a South Africa-based healthcare company. The Company is engaged in supplying specialty, branded and generic pharmaceutical products, hospital products, and fast-moving consumer goods (FMCG). Its segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the FMCG retail space. Its OTC segment focuses on brands sold predominantly in pharmacies. Its Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems. Its Other segment includes shared services and other support services, including regulatory services in India, as well as the investment in the Indian joint venture and cash and bank overdraft balances which are managed on a central basis in Southern Africa.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20236/30/2023Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
2844 Perfumes, cosmetics, and other toilet preparations
3845 Electromedical and electrotherapeutic apparatus
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Nompumelelo T.Madisa 44 2/22/2021 11/23/2018
Chief Executive Officer, Executive Director Andrew G.Hall 61 11/11/2015 9/1/2007
Chief Financial Officer, Executive Director DoretteNeethling 49 2/23/2016 8/1/2007
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Adcock Ingram Critical Care Pty Ltd. P.O. Box 6888 Johannesburg South Africa

Business Names
Business Name
Adcock Ingram Critical Care Proprietary Limited
Adcock Ingram East Africa Limited
Adcock Ingram Healthcare Proprietary Limited
13 additional Business Names available in full report.

General Information
Number of Employees: 2,388 (As of 6/30/2020)
Outstanding Shares: 151,026,000 (As of 12/31/2023)
Shareholders: 14,670
Stock Exchange: JNB
Fax Number: +27 865530000


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024